Work

Clarifying INSTINCT: Switching From Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Shows Comparable Inflammatory and Weight Outcomes

Year: 2025

Type: article

Abstract: Sergio Serrano-Villar, Santiago Moreno; Clarifying INSTINCT: Switching from DTG/3TC to BIC/FTC/TAF Shows Comparable Inflammatory and Weight Outcomes, Clini

Source: Clinical Infectious Diseases

DOI: 10.1093/cid/ciaf676

Authors: Sergio Serrano-Villar, Santiago Moreno

Institutions: Universidad de Alcalá, Universidad Nebrija, Centro de Investigación Biomédica en Red, Instituto Ramón y Cajal de Investigación Sanitaria, Hospital Universitario Ramón y Cajal, Centro de Investigación Biomédica en Red Enfermedades Infecciosas

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Gilead Sciences, ViiV Healthcare

OpenAlex ID: W4417178406

FWCI:

Cites: 14

Cited by:

Related to: